Diagnostic performance of unenhanced electrocardiogram-gated cardiac CT for detecting myocardial edema.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
17 May 2024
Historique:
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: ppublish

Résumé

To assess the diagnostic performance of unenhanced electrocardiogram (ECG)-gated cardiac computed tomography (CT) for detecting myocardial edema, using MRI T2 mapping as the reference standard. This retrospective study protocol was approved by our institutional review board, which waived the requirement for written informed consent. Between December 2017 to February 2019, consecutive patients who had undergone T2 mapping for myocardial tissue characterization were identified. We excluded patients who did not undergo unenhanced ECG-gated cardiac CT within 3 months from MRI T2 mapping or who had poor CT image quality. All patients underwent unenhanced ECG-gated cardiac CT with an axial scan using a third-generation, 320 × 0.5 mm detector-row CT unit. Two radiologists together drew regions of interest (ROIs) in the interventricular septum on the unenhanced ECG-gated cardiac CT images. Using T2 mapping as the reference standard, the diagnostic performance of unenhanced cardiac CT for detecting myocardial edema was evaluated by using the area under the receiver operating characteristic curve with sensitivity and specificity. Youden index was used to find an optimal sensitivity-specificity cutoff point. A cardiovascular radiologist independently performed the measurements, and interobserver reliability was assessed using intraclass correlation coefficients for CT value measurements. A P value of <.05 was considered statistically significant. We included 257 patients who had undergone MRI T2 mapping. Of the 257 patients, 35 patients underwent unenhanced ECG-gated cardiac CT. One patient was excluded from the study because of poor CT image quality. Finally, 34 patients (23 men; age 64.7 ± 14.6 years) comprised our study group. Using T2 mapping, we identified myocardial edema in 19 patients. Mean CT and T2 values for 34 patients were 46.3 ± 2.7 Hounsfield unit and 49.0 ± 4.9 ms, respectively. Mean CT values moderately correlated with mean T2 values (Rho = -0.41; P < .05). Mean CT values provided a sensitivity of 63.2% and a specificity of 93.3% for detecting myocardial edema, with a cutoff value of ≤45.0 Hounsfield unit (area under the receiver operating characteristic curve = 0.77; P < .01). Inter-observer reproducibility in measuring mean CT values was excellent (intraclass correlation coefficient = 0.93; [95% confidence interval: 0.86, 0.96]). Myocardial edema could be detected by CT value of myocardium in unenhanced ECG-gated cardiac CT.

Identifiants

pubmed: 38758838
doi: 10.1097/MD.0000000000038295
pii: 00005792-202405170-00001
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e38295

Informations de copyright

Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Friedrich MG, Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circ Cardiovasc Imaging. 2013;6:833–9.
Walls MC, Verhaert D, Min JK, Raman SV. Myocardial edema imaging in acute coronary syndromes. J Magn Reson Imaging. 2011;34:1243–50.
Galan-Arriola C, Lobo M, Vilchez-Tschischke JP, et al. Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity. J Am Coll Cardiol. 2019;73:779–91.
Kotecha T, Martinez-Naharro A, Treibel TA, et al. Myocardial edema and prognosis in amyloidosis. J Am Coll Cardiol. 2018;71:2919–31.
Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75.
Kim PK, Hong YJ, Im DJ, et al. Myocardial T1 and T2 mapping: techniques and clinical applications. Korean J Radiol. 2017;18:113–31.
Patel AR, Kramer CM. Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1180–93.
Lota AS, Gatehouse PD, Mohiaddin RH. T2 mapping and T2* imaging in heart failure. Heart Fail Rev. 2017;22:431–40.
Ter-Pogossian MM, Weiss ES, Coleman RE, Sobel BE. Computed tomography of the heart. AJR Am J Roentgenol. 1976;127:79–90.
Skioldebrand CG, Lipton MJ, Redington RW, Berninger WH, Wallace A, Carlsson E. Myocardial infarction in dogs, demonstrated by non-enhanced computed tomography. Acta Radiol Diagn (Stockh). 1981;22:1–8.
Mahnken AH, Bruners P, Bornikoel CM, Kramer N, Guenther RW. Assessment of myocardial edema by computed tomography in myocardial infarction. JACC Cardiovasc Imaging. 2009;2:1167–74.
Oda S, Kidoh M, Takashio S, et al. Quantification of myocardial extracellular volume with planning computed tomography for transcatheter aortic valve replacement to identify occult cardiac amyloidosis in patients with severe aortic stenosis. Circ Cardiovasc Imaging. 2020;13:e010358.
Chang S, Han K, Youn JC, et al. Utility of dual-energy CT-based monochromatic imaging in the assessment of myocardial delayed enhancement in patients with cardiomyopathy. Radiology. 2018;287:442–51.
Kidoh M, Oda S, Takashio S, et al. CT extracellular volume fraction versus myocardium-to-lumen signal ratio for cardiac amyloidosis. Radiology. 2023;306:e220542.
Oyama-Manabe N, Oda S, Ohta Y, Takagi H, Kitagawa K, Jinzaki M. Myocardial late enhancement and extracellular volume with single-energy, dual-energy, and photon-counting computed tomography. J Cardiovasc Comput Tomogr. 2024;18:3–10.
Agricola E, Beneduce A, Esposito A, et al. Heart and lung multimodality imaging in COVID-19. JACC Cardiovasc Imaging. 2020;13:1792–808.
Jessen KA, Shrimpton PC, Geleijns J, Panzer W, Tosi G. Dosimetry for optimisation of patient protection in computed tomography. Appl Radiat Isot. 1999;50:165–72.
Kumar V, Harfi TT, He X, et al. Estimation of myocardial fibrosis in humans with dual energy CT. J Cardiovasc Comput Tomogr. 2019;13:315–8.
Kumar V, McElhanon KE, Min JK, et al. Non-contrast estimation of diffuse myocardial fibrosis with dual energy CT: a phantom study. J Cardiovasc Comput Tomogr. 2018;12:74–80.
Robinson AA, Chow K, Salerno M. Myocardial T1 and ECV measurement: underlying concepts and technical considerations. JACC Cardiovasc Imaging. 2019;12(11 Pt 2):2332–44.
Mavrogeni S, Papavasiliou A, Giannakopoulou K, et al. Oedema-fibrosis in duchenne muscular dystrophy: role of cardiovascular magnetic resonance imaging. Eur J Clin Invest. 2017;47. doi: 10.1111/eci.12843
doi: 10.1111/eci.12843
Kidoh M, Oda S, Nakaura T, et al. Myocardial tissue characterization by combining extracellular volume fraction and T2 mapping. JACC Cardiovasc Imaging. 2022;15:700–4.
Vonder M, van der Werf NR, Leiner T, et al. The impact of dose reduction on the quantification of coronary artery calcifications and risk categorization: a systematic review. J Cardiovasc Comput Tomogr. 2018;12:352–63.
van Velzen SGM, Lessmann N, Velthuis BK, et al. Deep learning for automatic calcium scoring in CT: validation using multiple cardiac CT and Chest CT Protocols. Radiology. 2020;295:66–79.
Emoto T, Kidoh M, Oda S, et al. Myocardial extracellular volume quantification in cardiac CT: comparison of the effects of two different iterative reconstruction algorithms with MRI as a reference standard. Eur Radiol. 2020;30:691–701.
Funama Y, Oda S, Kidoh M, Sakabe D, Nakaura T. Effect of image quality on myocardial extracellular volume quantification using cardiac computed tomography: a phantom study. Acta Radiol. 2022;63:159–65.

Auteurs

Takafumi Emoto (T)

Department of Central Radiology, Kumamoto University Hospital, Chuo-ku, Kumamoto, Japan.

Masafumi Kidoh (M)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Seitaro Oda (S)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Daisuke Sakabe (D)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Kosuke Morita (K)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Masahiro Hatemura (M)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Takeshi Nakaura (T)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Yasunori Nagayama (Y)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Taihei Inoue (T)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Yoshinori Funama (Y)

Department of Medical Physics, Faculty of Life Sciences, Chuo-ku, Kumamoto, Japan.

Seiji Takashio (S)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Chuo-ku, Kumamoto, Japan.

Toshinori Hirai (T)

Department of Diagnostic Radiology, Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH